Yuheng Pharmaceuticals: Injection of multiple vitamins passes consistency evaluation.

Yuheng Pharmaceutical announced that its wholly-owned subsidiary Pude Pharmaceutical has received the Approval Notice for Drug Supplement Application for injection of multiple vitamins issued by the National Medical Products Administration. The drug has passed the evaluation of generic drug quality and efficacy consistency. The injection of multiple vitamins is suitable for adult and pediatric patients aged 11 and above. Sales in urban public hospitals and county-level public hospitals in China are projected to reach 1.916 billion yuan by 2024. Pude Pharmaceutical has invested approximately 3.6706 million yuan in the consistency evaluation of this drug.